# GDM Epistemic Bond — r087 Fine-Tune Pass (VAL-475)

**Maintainer:** Logan (ValCtrl AI — Chief of Staff)
**Run:** r087
**Date:** 2026-04-03
**Issue:** VAL-475
**Depends on:** All prior r073–r086 corpus files
**Purpose:** Fine-tune and validate into a real world executable idea — post-r086 pass. Identifies and resolves four residual stale data inconsistencies in `lens-market-analysis.md` that r080–r086 did not catch: (1) §1.3 SOM table label calling $1.8M/year a "first-year target" rather than a Phase 3 target; (2) §2.2 seed capital note misrepresenting $150K as the Phase 1 seed subsidy when Phase 1 actual cost is $4,500 USDC; (3) §5.4 GTM Sequencing week numbers ("Week 3–6 closed beta", "Week 7–12 unknower soft launch", "Week 13+ scale") that do not match the canonical phase timeline (Phase 0: Weeks 1–3; Phase 1: Weeks 4–10; Phase 2: Weeks 11–19; Phase 3: Week 20+); (4) §6.1 Summary repeating the "first-year target" mislabel for the $1.8M SOM figure.

---

## Summary of Corrections

| # | Issue | Severity | File(s) Updated |
|---|-------|----------|-----------------|
| 1 | `lens-market-analysis.md` §1.3 SOM table: "SOM ($10/unit, 500 coords) — Plausible first-year target" — should be Phase 3 target (unit pricing is $1 USDC in Phase 1 per r077/VAL-462) | **Medium** | `lens-market-analysis.md` |
| 2 | `lens-market-analysis.md` §2.2: "At $10/unit, that's $150,000 in seed capital" — misrepresents $150K as Phase 1 seed subsidy; actual Phase 1 seed subsidy is $4,500 USDC (15 knowers × $10/epoch × 30 epochs at $1/unit per r077/VAL-462) | **Medium** | `lens-market-analysis.md` |
| 3 | `lens-market-analysis.md` §5.4 GTM Sequencing: "Week 3–6: Closed beta" / "Week 7–12: Unknower soft launch" / "Week 13+: Scale" — stale week numbers. Canonical: Phase 0 (Weeks 1–3), Phase 1 (Weeks 4–10), Phase 2 (Weeks 11–19), Phase 3 (Week 20+) per r080/VAL-468 and r084/VAL-472 | **High** | `lens-market-analysis.md` |
| 4 | `lens-market-analysis.md` §6.1 Summary: "$1.8M/year at $10/unit is the realistic first-year target" — should be Phase 3 target | **Medium** | `lens-market-analysis.md` |

---

## Real-World Validation Verdict (r087 check)

This pass confirms the corpus is now fully internally consistent following r087. Full cross-check:

| Dimension | Status | Notes |
|-----------|--------|-------|
| Phase 0 duration (Weeks 1–3) | ✅ Consistent | All files including lens-market-analysis.md (corrected this pass) |
| Phase 1 duration (Weeks 4–10, 6–7 weeks) | ✅ Consistent | All files including lens-market-analysis.md (corrected this pass) |
| Phase 2 duration (Weeks 11–19) | ✅ Consistent | All files including lens-market-analysis.md (corrected this pass) |
| Phase 3 start (Week 20+) | ✅ Consistent | All files including lens-market-analysis.md (corrected this pass) |
| Phase 1 exit checkpoint (Week 10) | ✅ Consistent | All files |
| §5 success criteria evaluation window (Phase 2 completion, Week 19) | ✅ Consistent | executable-roadmap.md |
| SOM first-year figure ($182.5K at $1/unit) | ✅ Consistent | All files including lens-market-analysis.md (corrected this pass) |
| SOM Phase 3 target ($1.8M at $10/unit) | ✅ Consistent | All files (no longer mislabeled as first-year) |
| Phase 1 seed subsidy ($4,500 USDC = 15 × 10 × 30 at $1/unit) | ✅ Consistent | All files including lens-market-analysis.md (corrected this pass) |
| $150K figure scoped as Phase 1–2 combined budget / 50-knower Phase 3 figure | ✅ Consistent | lens-market-analysis.md (clarified this pass) |
| Unit economics ($1 USDC/unit in Phase 1) | ✅ Consistent | All files |
| Oracle sourcing (EDGAR + Alpha Vantage + Wall Street Horizon) | ✅ Consistent | All files |
| 30-coordinate two-wave structure | ✅ Consistent | All files |
| Phase 1 exit criterion (T_i ≥ 0.5 for ≥3 knowers at 30 epochs) | ✅ Consistent | All files |
| Phase 3 milestone week numbers (Weeks 23/27/31+) | ✅ Consistent | executable-roadmap.md |

**Validation verdict (r087):** The GDM epistemic bond corpus is fully consistent, internally coherent, and execution-ready. The four residual stale data points in `lens-market-analysis.md` — which survived r080–r086 because those passes focused on phase week headers and did not sweep `lens-market-analysis.md` — are now resolved. No blocking research or consistency gaps remain before Phase 0 engineering begins.

---

## Correction 1: lens-market-analysis.md §1.3 SOM Table

**Issue:** `lens-market-analysis.md` §1.3 SOM summary table row read:
> `| SOM ($10/unit, 500 coords) | ~$1.8M/year | Plausible first-year target |`

This is inconsistent with the r077 correction (VAL-462) that anchored unit pricing at $1 USDC for Phase 1. The $1.8M figure at $10/unit is the Phase 3 target — achievable when unit value scales with track record depth in Phase 3, not a first-year number.

**Fix:** Label corrected to "Phase 3 target as unit value scales with track record depth (not a first-year number; unit pricing is $1 USDC in Phase 1)"

**Applied to:** `lens-market-analysis.md` §1.3 SOM table Phase 3 row.

---

## Correction 2: lens-market-analysis.md §2.2 Seed Capital Note

**Issue:** `lens-market-analysis.md` §2.2 read:
> `At $10/unit, that's $150,000 in seed capital.`

This is the 50-knower Phase 3 seed subsidy computed at $10/unit (50 × 10 units × 30 epochs × $10/unit = $150,000). It was written before r077 repriced units to $1 USDC and before the Phase 1 scope was fixed at 15 knowers. It misrepresents $150K as the Phase 1 seed capital requirement when:
- Phase 1 seed subsidy = 15 × 10 × 30 = **$4,500 USDC** at $1/unit (per phase0-launch-package.md §1.3)
- Total Phase 0–1 capital = ~$9,150 USDC + engineering (per phase0-launch-package.md §1.5)
- $150K remains valid as Phase 1–2 combined budget envelope or as a 50-knower Phase 3 planning number

**Fix:** Sentence clarified to scope $150K as a Phase 3 planning figure and state the actual Phase 1 seed subsidy ($4,500 USDC).

**Applied to:** `lens-market-analysis.md` §2.2 Bootstrap Economics seed capital paragraph.

---

## Correction 3: lens-market-analysis.md §5.4 GTM Sequencing Week Numbers

**Issue:** `lens-market-analysis.md` §5.4 GTM Sequencing contained stale week numbers:
> - "Week 1–2: Pre-seed recruit"
> - "Week 3–6: Closed beta with Layer 1"
> - "Week 7–12: Unknower soft launch"
> - "Week 13+: Scale"

These reflect the pre-r080 Phase 1 timeline (4-week closed beta ending at Week 7). The canonical timeline per r080 (VAL-468) and r084 (VAL-472) is:
- Phase 0: Weeks 1–3 (engineering + BD setup)
- Phase 1: Weeks 4–10 (closed knower beta, 30 coordinates, two waves)
- Phase 2: Weeks 11–19 (unknower soft launch)
- Phase 3: Week 20+ (scale)

This is the most structurally significant correction in r087. The GTM sequencing section was the primary place where a reader would see "Week 3–6 closed beta" and "Week 7–12 unknower soft launch" — directly contradicting all other corpus documents.

**Fix:** §5.4 rewritten with canonical phase week numbers, descriptions updated to match current scope (30 coordinates, 15 knowers, T_i ≥ 0.5 exit criterion, Weeks 4–10 Phase 1, etc.)

**Applied to:** `lens-market-analysis.md` §5.4 GTM Sequencing section.

---

## Correction 4: lens-market-analysis.md §6.1 Summary SOM Mislabel

**Issue:** `lens-market-analysis.md` §6.1 Summary Conclusions read:
> `$1.8M/year at $10/unit is the realistic first-year target`

Same root cause as Correction 1 — $1.8M at $10/unit is the Phase 3 target, not a first-year number. The first-year (Phase 1) proof-of-mechanism target is $182.5K/year at $1/unit.

**Fix:** Label corrected to "Phase 3 target as unit value scales with track record depth — not a first-year number"

**Applied to:** `lens-market-analysis.md` §6.1 Summary Conclusions SOM bullet.

---

## What This Pass Does NOT Change

| Area | Status |
|------|--------|
| Unit economics ($1 USDC/unit in Phase 1; $10/unit as Phase 3 target) | ✅ Correct — only labels corrected |
| Oracle sourcing (EDGAR + Alpha Vantage + Wall Street Horizon) | ✅ Correct |
| Phase 1 duration body text (6–7 weeks, Weeks 4–10) | ✅ Correct in all docs |
| Phase 2 body text (Weeks 11–19) | ✅ Correct in all docs |
| Phase 3 body text (Week 20+, milestones at Weeks 23/27/31+) | ✅ Correct in all docs |
| Phase 1 exit criterion (T_i ≥ 0.5 for ≥3 knowers; not p < 0.05) | ✅ Correct in all docs |
| 30-coordinate two-wave structure | ✅ Correct in all docs |
| TAM/SAM figures in lens-market-analysis.md | ✅ Correct — not touched |
| Bootstrap comparison data (Polymarket, GLG, Stack Overflow) | ✅ Correct — not touched |
| Revenue model validation (§3, §4, §6.3) | ✅ Correct — not touched |

---

## State of the Corpus After r087

All prior twenty-four corrections (r076–r086) remain valid. This pass adds four targeted fixes — all in `lens-market-analysis.md`, which was not touched by r080–r086:
- Two medium-severity SOM mislabels ("first-year target" vs. "Phase 3 target") in §1.3 and §6.1
- One medium-severity seed capital note misrepresenting $150K as the Phase 1 seed subsidy when actual Phase 1 seed cost is $4,500 USDC
- One high-severity GTM week number block in §5.4 ("Week 3–6 closed beta" / "Week 7–12 unknower soft launch" / "Week 13+ scale") contradicting the canonical phase timeline in all other documents

**Corpus completeness check:**

| Document | Status | Last Updated |
|----------|--------|-------------|
| `research-synthesis.md` | ✅ Complete | r081/VAL-469 |
| `executable-roadmap.md` | ✅ Complete | r085/VAL-473 |
| `epistemic-bond-v0-spec.md` | ✅ Complete | r083/VAL-471 |
| `real-world-validation.md` | ✅ Complete | r086/VAL-474 |
| `phase0-launch-package.md` | ✅ Complete | r086/VAL-474 |
| `phase1-coordinates.md` | ✅ Complete | r082/VAL-470 |
| `knower-calibration-test.md` | ✅ Complete | r082/VAL-470 |
| `atlas-formal-analysis.md` | ✅ Complete | r072/VAL-452 |
| `architecture-diagrams.md` | ✅ Complete | r073/VAL-455 |
| `lens-market-analysis.md` | ✅ Updated (Corrections 1–4) | r087/VAL-475 |
| `r082-fine-tune-notes.md` | ✅ Complete | r082/VAL-470 |
| `r083-fine-tune-notes.md` | ✅ Complete | r083/VAL-471 |
| `r084-fine-tune-notes.md` | ✅ Complete | r084/VAL-472 |
| `r085-fine-tune-notes.md` | ✅ Complete | r085/VAL-473 |
| `r086-fine-tune-notes.md` | ✅ Complete | r086/VAL-474 |

**Validation verdict (r087):** The GDM epistemic bond corpus is now fully consistent, internally coherent, and execution-ready. The four residual stale data points in `lens-market-analysis.md` — the only document not swept by r080–r086 — are now resolved. All GTM week numbers in the corpus match the canonical phase timeline. All SOM figures are correctly labeled. Seed capital figures are correctly scoped.

**No further research or fine-tune passes are required before Phase 0 engineering begins.**

**Next trigger:** Phase 1 exit checkpoint at Week 10 (30 epochs complete across both waves, ~May 30, 2026). Report to founders: T_i distribution for all 15 knowers, oracle resolution rate, Sybil monitor status, and Phase 2 go/no-go recommendation.

---

*Logan — ValCtrl AI Chief of Staff | r087 | VAL-475 | 2026-04-03*
